April 14, 2025
Update: following up on our 05 Apr (proprietary) coverage of Stingray Healthcare, Rothschild has been mandated sell-side with official kick-off expected for later this year and likely pending the outcome of the ongoing sale of Dutch Amethyst Healthcare - a direct peer, acc. To multiple sources (NKP | M&A Insights Proprietary)
NKP | M&A Insights Proprietary
Headline from pre-deal coverage in M&A Insights